Variable Universal Life
Variable Universal Life (VUL) is a type of permanent life insurance that combines flexible premiums and an adjustable death benefit with a cash value component that can be invested in sub-accounts resembling mutual funds.
Variable universal life insurance sits at the intersection of life insurance and securities regulation. Because the cash value is invested in market-linked sub-accounts, VUL policies are classified as securities and must be sold by a licensed securities representative using a prospectus. This distinguishes VUL from whole life and traditional universal life policies, which are regulated exclusively as insurance products.
The cash value grows (or declines) based on the performance of the chosen sub-accounts, which typically include stock, bond, and money market options. Unlike whole life insurance, there is no guaranteed minimum cash value — poor investment performance can erode the account to zero, causing the policy to lapse unless the policyholder pays additional premiums. This market risk is the defining downside of VUL relative to other permanent life products.
The upside is tax-deferred growth on the cash value, the ability to take tax-free loans against the cash value, and a death benefit that remains free of federal income tax for the beneficiary. Policyholders who have maximized contributions to 401(k) and IRA accounts sometimes use VUL as an additional tax-advantaged vehicle, provided they are comfortable with the insurance costs embedded in the premium structure.
Those insurance costs — including mortality and expense (M&E) charges, cost of insurance (COI) charges, sub-account expense ratios, and administrative fees — are substantial. In many policies, these charges materially reduce net returns relative to investing in the same sub-accounts through a taxable brokerage account. The economics favor VUL mainly for high earners who hold the policy for very long periods and take full advantage of the tax treatment.
Policy illustrations, which project future cash values under various assumed return scenarios, must be reviewed critically. Regulators have addressed illustration abuse, but prospective buyers should stress-test projections at lower assumed returns than those highlighted in sales materials.